tiprankstipranks
Advertisement
Advertisement

CTMX Stock Latest News

CytomX Therapeutics participates in a conference call with JPMorgan
The FlyCytomX Therapeutics participates in a conference call with JPMorgan
14d ago
CTMX
CytomX Therapeutics Signals Progress in Varseta-M Trial
PremiumCompany Announcements
CytomX Therapeutics Signals Progress in Varseta-M Trial
25d ago
CTMX
3 Best Stocks to Buy Today, 3/23/2026, According to Top Analysts
PremiumMarket News
3 Best Stocks to Buy Today, 3/23/2026, According to Top Analysts
1M ago
COYA
CTMX
CytomX Therapeutics price target raised to $12 from $10 at Piper Sandler
PremiumThe Fly
CytomX Therapeutics price target raised to $12 from $10 at Piper Sandler
1M ago
CTMX
CytomX Therapeutics Raises $234 Million in Equity Offering
PremiumCompany Announcements
CytomX Therapeutics Raises $234 Million in Equity Offering
1M ago
8K
CTMX
CytomX Therapeutics price target raised to $16 from $10 at Barclays
PremiumThe FlyCytomX Therapeutics price target raised to $16 from $10 at Barclays
1M ago
CTMX
CytomX Therapeutics price target raised to $16 from $8 at Jefferies
Premium
The Fly
CytomX Therapeutics price target raised to $16 from $8 at Jefferies
1M ago
CTMX
CytomX Therapeutics price target raised to $15 from $10 at Guggenheim
Premium
The Fly
CytomX Therapeutics price target raised to $15 from $10 at Guggenheim
1M ago
CTMX
CytomX Therapeutics 45.9M share Secondary priced at $5.30
PremiumThe Fly
CytomX Therapeutics 45.9M share Secondary priced at $5.30
1M ago
CTMX
Midday Fly By: Nvidia bullish on AI revenue, MasterCard to acquire BVNK
PremiumThe Fly
Midday Fly By: Nvidia bullish on AI revenue, MasterCard to acquire BVNK
1M ago
BA
BW
CytomX Therapeutics price target raised to $11 from $6 at Wedbush
PremiumThe Fly
CytomX Therapeutics price target raised to $11 from $6 at Wedbush
1M ago
CTMX
CytomX Therapeutics Confronts Rising AI Regulatory Risks and Cost Pressures
PremiumCompany Announcements
CytomX Therapeutics Confronts Rising AI Regulatory Risks and Cost Pressures
1M ago
CTMX
CytomX Therapeutics announces $250M common stock offering
PremiumThe FlyCytomX Therapeutics announces $250M common stock offering
1M ago
CTMX
CytomX Therapeutics files automatic mixed securities shelf
Premium
The Fly
CytomX Therapeutics files automatic mixed securities shelf
1M ago
CTMX
Varseta-M’s Differentiated Efficacy in Late-Line Colorectal Cancer Drives Higher Approval Odds and Upside to Target Price
Premium
Ratings
Varseta-M’s Differentiated Efficacy in Late-Line Colorectal Cancer Drives Higher Approval Odds and Upside to Target Price
1M ago
CTMX
CytomX Therapeutics price target raised to $17 from $10 at H.C. Wainwright
PremiumThe Fly
CytomX Therapeutics price target raised to $17 from $10 at H.C. Wainwright
1M ago
CTMX
Midday Fly By: Meta said to eye job cuts, Dollar Tree up after earnings
PremiumThe Fly
Midday Fly By: Meta said to eye job cuts, Dollar Tree up after earnings
1M ago
JD
MU
CytomX Therapeutics upgraded to Overweight at JPMorgan after late-line CRC data
PremiumThe Fly
CytomX Therapeutics upgraded to Overweight at JPMorgan after late-line CRC data
1M ago
CTMX
CytomX Therapeutics upgraded to Overweight from Neutral at JPMorgan
PremiumThe Fly
CytomX Therapeutics upgraded to Overweight from Neutral at JPMorgan
1M ago
CTMX
CytomX Therapeutics price target raised to $12 from $10 at Oppenheimer
PremiumThe FlyCytomX Therapeutics price target raised to $12 from $10 at Oppenheimer
1M ago
CTMX
Nasus Pharma’s Positive Phase 2 Data Validates the Speed and Reliability of the NS002 Powder Platform
Premium
TipRanks Newswire
Nasus Pharma’s Positive Phase 2 Data Validates the Speed and Reliability of the NS002 Powder Platform
1M ago
CTMX
NSRX
Options Volatility and Implied Earnings Moves Today, March 16, 2026
Premium
Market News
Options Volatility and Implied Earnings Moves Today, March 16, 2026
1M ago
NIU
AGEN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >